Treatment Outcome Prediction for Lung Volume Reduction Procedures
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,226,299 | Treatment Outcome Prediction for Lung Volume Reduction Procedures In force · High confidence | Vida Daignostics, Inc. | In force | High confidence | ||
| US 9,504,529 | Treatment Outcome Prediction for Lung Volume Reduction Procedures In force · High confidence | Vida Diagnostics, Inc. | In force | High confidence | ||
| US 11,304,756 | Treatment Outcome Prediction for Lung Volume Reduction Procedures Lapsed Apr 19, 2026 on the fee record Ended Apr 19, 2026 · Medium confidence | Vida Diagnostics, Inc. | Lapsed Apr 19, 2026 on the fee record | Ended Apr 19, 2026 | Medium confidence |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Vida Diagnostics, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.